Erbitux® (cetuximab)
for Colorectal Cancer

Erbitux (cetuximab) is a targeted cancer therapy used to treat colorectal cancer and head and neck cancer. It works by blocking the epidermal growth factor receptor (EGFR), which helps slow the growth and spread of cancer cells. Erbitux is often used in combination with other cancer treatments, such as chemotherapy or radiation therapy.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Colorectal Cancer - CRC